FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,643 Cr | ₹3,317 Cr | ₹3,180 Cr | ₹3,038 Cr | ₹2,655 Cr |
What is the latest Total Liabilities ratio of FDC ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,643 Cr |
| Mar2024 | ₹3,317 Cr |
| Mar2023 | ₹3,180 Cr |
| Mar2022 | ₹3,038 Cr |
| Mar2021 | ₹2,655 Cr |
How is Total Liabilities of FDC Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,643 Cr | 9.85 | |
| Mar2024 | ₹3,317 Cr | 4.31 | |
| Mar2023 | ₹3,180 Cr | 4.66 | |
| Mar2022 | ₹3,038 Cr | 14.41 | |
| Mar2021 | ₹2,655 Cr | - | |
Compare Total Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,026.9 Cr | -4.6% | -9.1% | -17.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -4.6% |
-9.1% |
-17.2% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses